Minneapolis pharma company could be on cusp of changing stroke treatment
March 22, 2022 at 07:51 AM EDT
"By being the first to figure out how to manufacture an active synthetic form of this protein, we now have a version to bring to the West, U.S. and Europe," Pauls said.
